The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Enoxaparin API Market Research Report 2022

Global Enoxaparin API Market Research Report 2022

Publishing Date : May, 2022

License Type :
 

Report Code : 1696758

No of Pages : 94

Synopsis

Enoxaparin is made from heparin and is one type of the low molecular weight heparin (LMWH). It is used as an anticoagulant that prevents the formation of blood clots also known as ‘blood thinner’. It is used to treat various conditions including deep vein thrombosis (DVT), pulmonary embolism in the lungs, acute coronary syndrome and heart attack.

Due to the COVID-19 pandemic, the global Enoxaparin API market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Enoxaparin API market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Enoxaparin API landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Multi Vials accounting for % of the Enoxaparin API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While COVID-19 segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Enoxaparin API include Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc, Bristol Myer Squibb Company, Bohehringer Ingelheim, Eisai Inc., Teva Pharmaceutical Industries Ltd., Abbot India Limited, Novartis AG and ChemWerth, etc. In terms of revenue, the global 3 largest players have a % market share of Enoxaparin API in 2021.
This report focuses on Enoxaparin API volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Enoxaparin API market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Global Enoxaparin API Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Packaging and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Packaging

  • Multi Vials
  • Pre-Filled Syringes
  • Others

Segment by Application

  • COVID-19
  • Pulmonary Embolism
  • Atrial Fibrillation
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia) 
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Pfizer Inc.
  • Sanofi S.A.
  • GlaxoSmithKline Plc
  • Bristol Myer Squibb Company
  • Bohehringer Ingelheim
  • Eisai Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Abbot India Limited, Novartis AG
  • ChemWerth
  • Laboratorios Farmaceuticos ROVI SA
  • Gland Pharma Limited
  • Hanways Chempharma Co. Ltd
  • Changzhou Qianhong Biopharma
  • Shenzhen Hepalink Pharmaceutical Group
Index

1 Enoxaparin API Market Overview
1.1 Product Overview and Scope of Enoxaparin API
1.2 Enoxaparin API Segment by Packaging
1.2.1 Global Enoxaparin API Sales Growth Rate Comparison by Packaging (2022-2028)
1.2.2 Multi Vials
1.2.3 Pre-Filled Syringes
1.2.4 Others
1.3 Enoxaparin API Segment by Application
1.3.1 Global Enoxaparin API Sales Comparison by Application: (2022-2028)
1.3.2 COVID-19
1.3.3 Pulmonary Embolism
1.3.4 Atrial Fibrillation
1.3.5 Others
1.4 Global Enoxaparin API Market Size Estimates and Forecasts
1.4.1 Global Enoxaparin API Revenue 2017-2028
1.4.2 Global Enoxaparin API Sales 2017-2028
1.4.3 Enoxaparin API Market Size by Region: 2017 Versus 2021 Versus 2028
2 Enoxaparin API Market Competition by Manufacturers
2.1 Global Enoxaparin API Sales Market Share by Manufacturers (2017-2022)
2.2 Global Enoxaparin API Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Enoxaparin API Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Enoxaparin API Manufacturing Sites, Area Served, Product Type
2.5 Enoxaparin API Market Competitive Situation and Trends
2.5.1 Enoxaparin API Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Enoxaparin API Players Market Share by Revenue
2.5.3 Global Enoxaparin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Enoxaparin API Retrospective Market Scenario by Region
3.1 Global Enoxaparin API Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Enoxaparin API Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Enoxaparin API Market Facts & Figures by Country
3.3.1 North America Enoxaparin API Sales by Country
3.3.2 North America Enoxaparin API Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Enoxaparin API Market Facts & Figures by Country
3.4.1 Europe Enoxaparin API Sales by Country
3.4.2 Europe Enoxaparin API Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Enoxaparin API Market Facts & Figures by Region
3.5.1 Asia Pacific Enoxaparin API Sales by Region
3.5.2 Asia Pacific Enoxaparin API Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Enoxaparin API Market Facts & Figures by Country
3.6.1 Latin America Enoxaparin API Sales by Country
3.6.2 Latin America Enoxaparin API Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Enoxaparin API Market Facts & Figures by Country
3.7.1 Middle East and Africa Enoxaparin API Sales by Country
3.7.2 Middle East and Africa Enoxaparin API Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Enoxaparin API Historic Market Analysis by Packaging
4.1 Global Enoxaparin API Sales Market Share by Packaging (2017-2022)
4.2 Global Enoxaparin API Revenue Market Share by Packaging (2017-2022)
4.3 Global Enoxaparin API Price by Packaging (2017-2022)
5 Global Enoxaparin API Historic Market Analysis by Application
5.1 Global Enoxaparin API Sales Market Share by Application (2017-2022)
5.2 Global Enoxaparin API Revenue Market Share by Application (2017-2022)
5.3 Global Enoxaparin API Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Corporation Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Pfizer Inc. Enoxaparin API Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 Sanofi S.A.
6.2.1 Sanofi S.A. Corporation Information
6.2.2 Sanofi S.A. Description and Business Overview
6.2.3 Sanofi S.A. Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Sanofi S.A. Enoxaparin API Product Portfolio
6.2.5 Sanofi S.A. Recent Developments/Updates
6.3 GlaxoSmithKline Plc
6.3.1 GlaxoSmithKline Plc Corporation Information
6.3.2 GlaxoSmithKline Plc Description and Business Overview
6.3.3 GlaxoSmithKline Plc Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
6.3.4 GlaxoSmithKline Plc Enoxaparin API Product Portfolio
6.3.5 GlaxoSmithKline Plc Recent Developments/Updates
6.4 Bristol Myer Squibb Company
6.4.1 Bristol Myer Squibb Company Corporation Information
6.4.2 Bristol Myer Squibb Company Description and Business Overview
6.4.3 Bristol Myer Squibb Company Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Bristol Myer Squibb Company Enoxaparin API Product Portfolio
6.4.5 Bristol Myer Squibb Company Recent Developments/Updates
6.5 Bohehringer Ingelheim
6.5.1 Bohehringer Ingelheim Corporation Information
6.5.2 Bohehringer Ingelheim Description and Business Overview
6.5.3 Bohehringer Ingelheim Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Bohehringer Ingelheim Enoxaparin API Product Portfolio
6.5.5 Bohehringer Ingelheim Recent Developments/Updates
6.6 Eisai Inc.
6.6.1 Eisai Inc. Corporation Information
6.6.2 Eisai Inc. Description and Business Overview
6.6.3 Eisai Inc. Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Eisai Inc. Enoxaparin API Product Portfolio
6.6.5 Eisai Inc. Recent Developments/Updates
6.7 Teva Pharmaceutical Industries Ltd.
6.6.1 Teva Pharmaceutical Industries Ltd. Corporation Information
6.6.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Ltd. Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Teva Pharmaceutical Industries Ltd. Enoxaparin API Product Portfolio
6.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
6.8 Abbot India Limited, Novartis AG
6.8.1 Abbot India Limited, Novartis AG Corporation Information
6.8.2 Abbot India Limited, Novartis AG Description and Business Overview
6.8.3 Abbot India Limited, Novartis AG Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Abbot India Limited, Novartis AG Enoxaparin API Product Portfolio
6.8.5 Abbot India Limited, Novartis AG Recent Developments/Updates
6.9 ChemWerth
6.9.1 ChemWerth Corporation Information
6.9.2 ChemWerth Description and Business Overview
6.9.3 ChemWerth Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
6.9.4 ChemWerth Enoxaparin API Product Portfolio
6.9.5 ChemWerth Recent Developments/Updates
6.10 Laboratorios Farmaceuticos ROVI SA
6.10.1 Laboratorios Farmaceuticos ROVI SA Corporation Information
6.10.2 Laboratorios Farmaceuticos ROVI SA Description and Business Overview
6.10.3 Laboratorios Farmaceuticos ROVI SA Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Laboratorios Farmaceuticos ROVI SA Enoxaparin API Product Portfolio
6.10.5 Laboratorios Farmaceuticos ROVI SA Recent Developments/Updates
6.11 Gland Pharma Limited
6.11.1 Gland Pharma Limited Corporation Information
6.11.2 Gland Pharma Limited Enoxaparin API Description and Business Overview
6.11.3 Gland Pharma Limited Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Gland Pharma Limited Enoxaparin API Product Portfolio
6.11.5 Gland Pharma Limited Recent Developments/Updates
6.12 Hanways Chempharma Co. Ltd
6.12.1 Hanways Chempharma Co. Ltd Corporation Information
6.12.2 Hanways Chempharma Co. Ltd Enoxaparin API Description and Business Overview
6.12.3 Hanways Chempharma Co. Ltd Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Hanways Chempharma Co. Ltd Enoxaparin API Product Portfolio
6.12.5 Hanways Chempharma Co. Ltd Recent Developments/Updates
6.13 Changzhou Qianhong Biopharma
6.13.1 Changzhou Qianhong Biopharma Corporation Information
6.13.2 Changzhou Qianhong Biopharma Enoxaparin API Description and Business Overview
6.13.3 Changzhou Qianhong Biopharma Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Changzhou Qianhong Biopharma Enoxaparin API Product Portfolio
6.13.5 Changzhou Qianhong Biopharma Recent Developments/Updates
6.14 Shenzhen Hepalink Pharmaceutical Group
6.14.1 Shenzhen Hepalink Pharmaceutical Group Corporation Information
6.14.2 Shenzhen Hepalink Pharmaceutical Group Enoxaparin API Description and Business Overview
6.14.3 Shenzhen Hepalink Pharmaceutical Group Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Shenzhen Hepalink Pharmaceutical Group Enoxaparin API Product Portfolio
6.14.5 Shenzhen Hepalink Pharmaceutical Group Recent Developments/Updates
7 Enoxaparin API Manufacturing Cost Analysis
7.1 Enoxaparin API Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Enoxaparin API
7.4 Enoxaparin API Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Enoxaparin API Distributors List
8.3 Enoxaparin API Customers
9 Enoxaparin API Market Dynamics
9.1 Enoxaparin API Industry Trends
9.2 Enoxaparin API Market Drivers
9.3 Enoxaparin API Market Challenges
9.4 Enoxaparin API Market Restraints
10 Global Market Forecast
10.1 Enoxaparin API Market Estimates and Projections by Packaging
10.1.1 Global Forecasted Sales of Enoxaparin API by Packaging (2023-2028)
10.1.2 Global Forecasted Revenue of Enoxaparin API by Packaging (2023-2028)
10.2 Enoxaparin API Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Enoxaparin API by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Enoxaparin API by Application (2023-2028)
10.3 Enoxaparin API Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Enoxaparin API by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Enoxaparin API by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Enoxaparin API Sales Growth Rate Comparison by Packaging (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Enoxaparin API Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Enoxaparin API Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Enoxaparin API Market Competitive Situation by Manufacturers in 2021
Table 5. Global Enoxaparin API Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Enoxaparin API Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Enoxaparin API Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Enoxaparin API Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Enoxaparin API Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Enoxaparin API Manufacturing Sites and Area Served
Table 11. Manufacturers Enoxaparin API Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Enoxaparin API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enoxaparin API as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Enoxaparin API Sales by Region (2017-2022) & (K Units)
Table 16. Global Enoxaparin API Sales Market Share by Region (2017-2022)
Table 17. Global Enoxaparin API Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Enoxaparin API Revenue Market Share by Region (2017-2022)
Table 19. North America Enoxaparin API Sales by Country (2017-2022) & (K Units)
Table 20. North America Enoxaparin API Sales Market Share by Country (2017-2022)
Table 21. North America Enoxaparin API Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Enoxaparin API Revenue Market Share by Country (2017-2022)
Table 23. Europe Enoxaparin API Sales by Country (2017-2022) & (K Units)
Table 24. Europe Enoxaparin API Sales Market Share by Country (2017-2022)
Table 25. Europe Enoxaparin API Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Enoxaparin API Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Enoxaparin API Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Enoxaparin API Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Enoxaparin API Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Enoxaparin API Revenue Market Share by Region (2017-2022)
Table 31. Latin America Enoxaparin API Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Enoxaparin API Sales Market Share by Country (2017-2022)
Table 33. Latin America Enoxaparin API Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Enoxaparin API Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Enoxaparin API Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Enoxaparin API Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Enoxaparin API Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Enoxaparin API Revenue Market Share by Country (2017-2022)
Table 39. Global Enoxaparin API Sales by Packaging (2017-2022) & (K Units)
Table 40. Global Enoxaparin API Sales Market Share by Packaging (2017-2022)
Table 41. Global Enoxaparin API Revenue by Packaging (2017-2022) & (US$ Million)
Table 42. Global Enoxaparin API Revenue Share by Packaging (2017-2022)
Table 43. Global Enoxaparin API Price by Packaging (2017-2022) & (US$/Unit)
Table 44. Global Enoxaparin API Sales (K Units) by Application (2017-2022)
Table 45. Global Enoxaparin API Sales Market Share by Application (2017-2022)
Table 46. Global Enoxaparin API Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Enoxaparin API Revenue Share by Application (2017-2022)
Table 48. Global Enoxaparin API Price by Application (2017-2022) & (US$/Unit)
Table 49. Pfizer Inc. Corporation Information
Table 50. Pfizer Inc. Description and Business Overview
Table 51. Pfizer Inc. Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Pfizer Inc. Enoxaparin API Product
Table 53. Pfizer Inc. Recent Developments/Updates
Table 54. Sanofi S.A. Corporation Information
Table 55. Sanofi S.A. Description and Business Overview
Table 56. Sanofi S.A. Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Sanofi S.A. Enoxaparin API Product
Table 58. Sanofi S.A. Recent Developments/Updates
Table 59. GlaxoSmithKline Plc Corporation Information
Table 60. GlaxoSmithKline Plc Description and Business Overview
Table 61. GlaxoSmithKline Plc Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. GlaxoSmithKline Plc Enoxaparin API Product
Table 63. GlaxoSmithKline Plc Recent Developments/Updates
Table 64. Bristol Myer Squibb Company Corporation Information
Table 65. Bristol Myer Squibb Company Description and Business Overview
Table 66. Bristol Myer Squibb Company Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Bristol Myer Squibb Company Enoxaparin API Product
Table 68. Bristol Myer Squibb Company Recent Developments/Updates
Table 69. Bohehringer Ingelheim Corporation Information
Table 70. Bohehringer Ingelheim Description and Business Overview
Table 71. Bohehringer Ingelheim Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Bohehringer Ingelheim Enoxaparin API Product
Table 73. Bohehringer Ingelheim Recent Developments/Updates
Table 74. Eisai Inc. Corporation Information
Table 75. Eisai Inc. Description and Business Overview
Table 76. Eisai Inc. Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Eisai Inc. Enoxaparin API Product
Table 78. Eisai Inc. Recent Developments/Updates
Table 79. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 80. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 81. Teva Pharmaceutical Industries Ltd. Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Teva Pharmaceutical Industries Ltd. Enoxaparin API Product
Table 83. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 84. Abbot India Limited, Novartis AG Corporation Information
Table 85. Abbot India Limited, Novartis AG Description and Business Overview
Table 86. Abbot India Limited, Novartis AG Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Abbot India Limited, Novartis AG Enoxaparin API Product
Table 88. Abbot India Limited, Novartis AG Recent Developments/Updates
Table 89. ChemWerth Corporation Information
Table 90. ChemWerth Description and Business Overview
Table 91. ChemWerth Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. ChemWerth Enoxaparin API Product
Table 93. ChemWerth Recent Developments/Updates
Table 94. Laboratorios Farmaceuticos ROVI SA Corporation Information
Table 95. Laboratorios Farmaceuticos ROVI SA Description and Business Overview
Table 96. Laboratorios Farmaceuticos ROVI SA Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Laboratorios Farmaceuticos ROVI SA Enoxaparin API Product
Table 98. Laboratorios Farmaceuticos ROVI SA Recent Developments/Updates
Table 99. Gland Pharma Limited Corporation Information
Table 100. Gland Pharma Limited Description and Business Overview
Table 101. Gland Pharma Limited Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Gland Pharma Limited Enoxaparin API Product
Table 103. Gland Pharma Limited Recent Developments/Updates
Table 104. Hanways Chempharma Co. Ltd Corporation Information
Table 105. Hanways Chempharma Co. Ltd Description and Business Overview
Table 106. Hanways Chempharma Co. Ltd Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Hanways Chempharma Co. Ltd Enoxaparin API Product
Table 108. Hanways Chempharma Co. Ltd Recent Developments/Updates
Table 109. Changzhou Qianhong Biopharma Corporation Information
Table 110. Changzhou Qianhong Biopharma Description and Business Overview
Table 111. Changzhou Qianhong Biopharma Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Changzhou Qianhong Biopharma Enoxaparin API Product
Table 113. Changzhou Qianhong Biopharma Recent Developments/Updates
Table 114. Shenzhen Hepalink Pharmaceutical Group Corporation Information
Table 115. Shenzhen Hepalink Pharmaceutical Group Description and Business Overview
Table 116. Shenzhen Hepalink Pharmaceutical Group Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Shenzhen Hepalink Pharmaceutical Group Enoxaparin API Product
Table 118. Shenzhen Hepalink Pharmaceutical Group Recent Developments/Updates
Table 119. Production Base and Market Concentration Rate of Raw Material
Table 120. Key Suppliers of Raw Materials
Table 121. Enoxaparin API Distributors List
Table 122. Enoxaparin API Customers List
Table 123. Enoxaparin API Market Trends
Table 124. Enoxaparin API Market Drivers
Table 125. Enoxaparin API Market Challenges
Table 126. Enoxaparin API Market Restraints
Table 127. Global Enoxaparin API Sales Forecast by Packaging (2023-2028) & (K Units)
Table 128. Global Enoxaparin API Sales Market Share Forecast by Packaging (2023-2028)
Table 129. Global Enoxaparin API Revenue Forecast by Packaging (2023-2028) & (US$ Million)
Table 130. Global Enoxaparin API Revenue Market Share Forecast by Packaging (2023-2028)
Table 131. Global Enoxaparin API Sales Forecast by Application (2023-2028) & (K Units)
Table 132. Global Enoxaparin API Sales Market Share Forecast by Application (2023-2028)
Table 133. Global Enoxaparin API Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 134. Global Enoxaparin API Revenue Market Share Forecast by Application (2023-2028)
Table 135. Global Enoxaparin API Sales Forecast by Region (2023-2028) & (K Units)
Table 136. Global Enoxaparin API Sales Market Share Forecast by Region (2023-2028)
Table 137. Global Enoxaparin API Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 138. Global Enoxaparin API Revenue Market Share Forecast by Region (2023-2028)
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Enoxaparin API
Figure 2. Global Enoxaparin API Market Share by Packaging in 2021 & 2028
Figure 3. Multi Vials Product Picture
Figure 4. Pre-Filled Syringes Product Picture
Figure 5. Others Product Picture
Figure 6. Global Enoxaparin API Market Share by Application in 2021 & 2028
Figure 7. COVID-19
Figure 8. Pulmonary Embolism
Figure 9. Atrial Fibrillation
Figure 10. Others
Figure 11. Global Enoxaparin API Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Enoxaparin API Market Size (2017-2028) & (US$ Million)
Figure 13. Global Enoxaparin API Sales (2017-2028) & (K Units)
Figure 14. Enoxaparin API Sales Share by Manufacturers in 2021
Figure 15. Global Enoxaparin API Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Enoxaparin API Players: Market Share by Revenue in 2021
Figure 17. Enoxaparin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Enoxaparin API Sales Market Share by Region (2017-2022)
Figure 19. Global Enoxaparin API Sales Market Share by Region in 2021
Figure 20. Global Enoxaparin API Revenue Market Share by Region (2017-2022)
Figure 21. Global Enoxaparin API Revenue Market Share by Region in 2021
Figure 22. United States Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China Taiwan Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. UAE Enoxaparin API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of Enoxaparin API by Packaging (2017-2022)
Figure 45. Manufacturing Cost Structure of Enoxaparin API
Figure 46. Manufacturing Process Analysis of Enoxaparin API
Figure 47. Enoxaparin API Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’